Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome (clinicaltrials.gov) - Aug 22, 2026 - P1 | N=42 | Not yet recruiting | Sponsor: M.D. Anderson Cancer Center
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Myelodysplastic Syndrome • Oncology • BCL2
|